Abstract

QUALITATIVE VALIDATION OF A NOVEL VIRTUAL REALITY (VR) PROGRAM FOR IRRITABLE BOWEL SYNDROME: A VR1 STUDY

Am J Gastroenterol. 2022 Jan 7. doi: 10.14309/ajg.0000000000001641. Online ahead of print.

Brennan M R Spiegel 1 2, Omer Liran 1 3, Rebecca Gale 1, Carine Khalil 1, Katherine Makaroff 1, Robert Chernoff 3, Tiffany Raber 4, Bianca Chang 2, Nipaporn Pichetshote 2, Ali Rezaie 2

 
     

Author information

1Cedars-Sinai Department of Medicine, Division of Health Services Research.

2Cedars-Sinai Department of Medicine, Division of Gastroenterology.

3Cedars-Sinai Department of Psychiatry and Behavioral Sciences.

4University of California, Irvine.

Abstract

Background: Although gut-directed psychotherapies are effective for IBS, they are rarely prescribed given a paucity of trained clinicians. Virtual reality (VR) offers a solution by allowing patients to self-practice these techniques in a standardized manner.

Methods: A multidisciplinary team developed IBS/VR, a program that transports users into immersive VR worlds that teach patients about the brain-gut axis, cognitive behavioral therapy, and gut-directed meditation. We tested IBS/VR in Rome IV IBS patients and used inductive analysis to evaluate perceptions and identify recommendations.

Results: We achieved thematic saturation after nine interviews; three additional interviews revealed no emergent themes. After making 23 software changes based on patient feedback, we conducted three additional interviews which confirmed thematic saturation (N=15 total).

Discussion: This study offers initial validation of the first VR program designed for IBS.

© Copyright 2013-2022 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.